Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?

J HIV Ther. 2009 Mar;14(1):8-12.

Authors

Martin Vogel¹, Emma Page, Mark Nelson, Jürgen K Rockstroh

Affiliation

¹ University of Bonn, Germany.

PMID: 19731559

No abstract available

Publication types

Review

MeSH terms

Acute Disease
Antiviral Agents / therapeutic use*
CD4 Lymphocyte Count
HIV Infections / epidemiology*
Hepatitis C / diagnosis
Hepatitis C / drug therapy*
Hepatitis C / epidemiology
Hepatitis C / transmission
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use
Polyethylene Glycols / therapeutic use
RNA, Viral / analysis
Recombinant Proteins
Ribavirin / therapeutic use
Risk Factors

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
RNA, Viral
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2b